Literature DB >> 33942601

Physical activity and medication in Brazilians suffering with non-communicable diseases in quarantine by COVID-19.

Márcio Doro1, Yara Ferreira Marques2, Heitor Felipe Cantarinho de Lima3, Willian De Oliveira Caccalano4, Aide Angélica De Oliveira Nessi5, Érico Chagas Caperuto6, Denise De Oliveira Alonso7, Daniel Leite Portella8.   

Abstract

This study aimed to compare the practice of physical activity in groups of people with chronic diseases with and without medication, before and during the pandemic. 298 Brazilian individuals with chronic non-communicable diseases such as cardiovascular, metabolic / endocrine, respiratory, orthopedic, gastrointestinal diseases, anxiety and depression were separated into two groups: with and without medication. A questionnaire with 14 questions was applied, tracing the behavioral profile in relation to physical exercises before and during isolation, interpreted through descriptive analysis, and the groups were compared through Mann-Whitman's statistics. The drop in the percentage of active individuals with or without medication occurred when comparing the scenarios before and during quarantine. However, the difference in the prevalence of active individuals between the groups was significant, showing that the group with medication remained more active. The fear of contamination, the measures of distance and the lack of adherence of the population to classes by videoconference reduced the frequency of physical activities in the general sample population. However, people who used medication showed greater concern about the practice of physical activity to optimize treatment. The isolation period had a negative impact on the practice of physical activity, regardless of the presence of some chronic disease or the use of medication.

Entities:  

Year:  2021        PMID: 33942601     DOI: 10.4081/ejtm.2021.9772

Source DB:  PubMed          Journal:  Eur J Transl Myol        ISSN: 2037-7452


  2 in total

1.  COVID-19 patients at referral to hospital during the first peak of disease: Common clinical findings including myalgia and fatigue.

Authors:  Amin Honarmand; Fateme Sheybani; Elahe Aflatoonian; Amin Saberinia
Journal:  Eur J Transl Myol       Date:  2022-08-12

2.  Intensive care unit-acquired weakness: A review from molecular mechanisms to its impact in COVID-2019.

Authors:  Andrea Gonzalez; Johanna Abrigo; Oscar Achiardi; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Eur J Transl Myol       Date:  2022-08-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.